US Patent Issued to Board of Regents, The University of Texas System on Dec. 2 for "Methods and compositions for TUSC2 immunotherapy" (Texas Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,159, issued on Dec. 2, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Methods and compositions for TUSC2 immunotherapy" was invented by Jack A. Roth (Houston) and Lin Ji (Sugar Land, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a subject having a cancer comprising administering a tumor suppressor therapy, such as a TUSC2 therapy, in conjunction with an immune checkpoint inhibitor. Kits and reagents for use in cancer therapy are also provided."

The patent was filed on Feb. 17, 2022, under Application No. 17/674,800.

*For further information, including images, charts and tables, please ...